3 European Projects Found
Searched on 125080 European Projects
FINISHED
Cancer Vaccine development for Hepatocellular Carcinoma (HepaVac)
Start date: Sep 1, 2013, End date: Aug 31, 2018,
"Hepatocellular carcinoma (HCC) is the most common primary liver cancer and accounts for about 6% of all new cancer cases worldwide. Given the lack of available effective treatments, the overall prognosis for HCC patients is poor, with a dismal 5-year survival of 5-6%. The main goal of this proposal is to develop a therapeutic cancer vaccine aiming at improving clinical outcome in early-stage HCC ...
Read Project
10
Partners Participants
FINISHED
Resveratrol-induced molecular markers in cancer and progenitor cells proliferation (Resveratrol roles)
Start date: Jan 1, 2011, End date: Dec 31, 2014,
Many genes that have been shown to cause cancer were originally identified because of their role in embryonic development and in the postnatal control of cell growth and differentiation. The similarities between cancer and development are evident on many levels. Microscopically, cancerous tissues frequently appear as undifferentiated masses, with some tumor types exhibiting embryonic tissue organ ...
Read Project
1
Partner Participant
FINISHED
Next Generation HIV-1 Immunogens inducing broadly reactive Neutralising antibodies (NGIN)
Start date: Feb 1, 2008, End date: Jul 31, 2012,
"The elicitation of broadly neutralising antibodies (Nab) remains the primary and most challenging goal in HIV-1 vaccine development. Although a few anti-HIV-1 monoclonal antibodies with broadly neutralising capability have been isolated from infected individuals, none of the immunization strategies thus far explored has proven effective in inducing similar antibodies. Objective of this applicatio ...
Read Project
